The impact of metabolic syndrome on left ventricular function: Evaluated by using the index of myocardial performance

Basit Öğe Kaydı
dc.authoridAkaycan, Jülide/0000-0002-9174-6777
dc.authorwosidAkaycan, Jülide/ABI-2397-2020
dc.contributor.authorTurhan, Hasan
dc.contributor.authorYasar, Ayse Saatci
dc.contributor.authorYagmur, Julide
dc.contributor.authorKurtoglu, Ertugrul
dc.contributor.authorYetkin, Ertan
dc.date.accessioned2024-08-04T20:31:08Z
dc.date.available2024-08-04T20:31:08Z
dc.date.issued2009
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAim: To evaluate the impact of metabolic syndrome on global left ventricular function by using the index of myocardial performance. Methods: The study population included 106 patients with metabolic syndrome (66 male, 40 female, mean age=54 +/- 11 years) and 106 control subjects without metabolic syndrome (71 male, 35 female, mean age=53 +/- 10). The diagnosis of metabolic syndrome was based on The National Cholesterol Education Program Adult Treatment Panel III criteria. All patients underwent two-dimensional and Doppler echocardiographic examination. The index of myocardial performance was determined as the sum of isovolumic relaxation time and isovolumic contraction time divided by left ventricular ejection time. Results: The index of myocardial performance was found to be significantly higher in patients with metabolic syndrome compared with control subjects without metabolic syndrome (0.55 +/- 0.06 vs 0.38 +/- 0.04 respectively, p < 0.001). Conclusion: In the present study, we have shown the presence of impaired global left ventricular function in patients with metabolic syndrome compared with control subjects without metabolic syndrome. This finding emphasizes the importance of early diagnosis and management of metabolic syndrome to prevent the progression of ventricular dysfunction to overt structural and symptomatic cardiac disease. (C) 2008 Published by Elsevier Ireland Ltd.en_US
dc.identifier.doi10.1016/j.ijcard.2007.12.007
dc.identifier.endpage386en_US
dc.identifier.issn0167-5273
dc.identifier.issn1874-1754
dc.identifier.issue3en_US
dc.identifier.pmid18262293en_US
dc.identifier.scopus2-s2.0-60649098976en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage382en_US
dc.identifier.urihttps://doi.org/10.1016/j.ijcard.2007.12.007
dc.identifier.urihttps://hdl.handle.net/11616/94755
dc.identifier.volume132en_US
dc.identifier.wosWOS:000263892200013en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Ireland Ltden_US
dc.relation.ispartofInternational Journal of Cardiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMetabolic syndromeen_US
dc.subjectMyocardial functionen_US
dc.subjectIndex of myocardial performanceen_US
dc.titleThe impact of metabolic syndrome on left ventricular function: Evaluated by using the index of myocardial performanceen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu